Black Diamond Therapeutics (BDTX) Insider Trading & Ownership $3.33 -0.11 (-3.20%) (As of 10/11/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics (NASDAQ:BDTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.87%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$936,000.00Number OfInsiders Selling(Last 12 Months)0 Get BDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BDTX Insider Buying and Selling by Quarter Ad Angel PublishingWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. Black Diamond Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/17/2023Growth N V BiotechMajor ShareholderBuy400,000$2.34$936,000.00 (Data available from 1/1/2013 forward) BDTX Insider Trading Activity - Frequently Asked Questions Who is on Black Diamond Therapeutics's Insider Roster? The list of insiders at Black Diamond Therapeutics includes Ali Behbahani, David M Epstein, Fang Ni, and Growth N V Biotech. Learn more on insiders at BDTX. What percentage of Black Diamond Therapeutics stock is owned by insiders? 8.87% of Black Diamond Therapeutics stock is owned by insiders. Learn more on BDTX's insider holdings. Which Black Diamond Therapeutics insiders have been buying company stock? The following insiders have purchased BDTX shares in the last 24 months: Ali Behbahani ($5,000,000.00), and Growth N V Biotech ($16,082,240.84). How much insider buying is happening at Black Diamond Therapeutics? Insiders have purchased a total of 4,497,217 BDTX shares in the last 24 months for a total of $21,082,240.84 bought. Which Black Diamond Therapeutics insiders have been selling company stock? The following insider sold BDTX shares in the last 24 months: David M Epstein ($167,500.00). How much insider selling is happening at Black Diamond Therapeutics? Insiders have sold a total of 25,000 Black Diamond Therapeutics shares in the last 24 months for a total of $167,500.00 sold. More Insider Trading Tools from MarketBeat Related Companies: Inhibrx Insider Ownership iTeos Therapeutics Insider Ownership C4 Therapeutics Insider Ownership Alector Insider Ownership Prothena Insider Ownership Phibro Animal Health Insider Ownership Zymeworks Insider Ownership Relay Therapeutics Insider Ownership IGM Biosciences Insider Ownership CARGO Therapeutics Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You? This page (NASDAQ:BDTX) was last updated on 10/13/2024 by MarketBeat.com Staff From Our PartnersHave you heard of Donald Trump’s Project Crypto?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredThe Great Crypto Frenzy 2.0 is About to StartBitcoin’s Final Bull Run: Three Altcoins to Get Into NOW! “Crypto Whisperer” Ian King is calling it: due to...Banyan Hill Publishing | Sponsored$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It'...Monument Traders Alliance | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDTX Stock Alerts